Navigation Links
Helix BioPharma Corp. Announces Fiscal 2009 Results
Date:10/29/2009

s totalled $18,000 in fiscal 2009 and $153,000 in fiscal 2008. Income taxes are attributable to the Company's operations in Ireland.

LIQUIDITY AND CAPITAL RESOURCES

Since inception, the Company has financed its operations from public and private sales of equity, the exercise of warrants and stock options, and, to a lesser extent, on interest income from funds available for investment, investment tax credits, and revenues from distribution, licensing and contract services. Since the Company does not have net earnings from its operations, the Company's long-term liquidity depends on its ability to access the capital markets, which depends substantially on the success of the Company's ongoing research and development programs.

At July 31, 2009 and 2008, the Company had cash and cash equivalents totaling $14,494,000 and $19,057,000, respectively. The $4,563,000 decrease in cash and cash equivalents reflects a use of cash in operating activities of $13,157,000 which includes a net loss for the year of $14,102,000. Operating activities were financed from a private placement which closed on October 2, 2008 for net proceeds of $9,659,000. Cash used in investing activities in the 2009 fiscal year total $932,000 which predominately reflects purchases of research and development equipment. Effect of exchange rate changes on cash and cash equivalents in fiscal 2009 represent a foreign exchange loss of $133,000.

At July 31, 2009 and 2008, the Company's working capital was $15,296,000 and $19,166,000, respectively.

On September 8, 2009, subsequent to Company's fiscal year ended July 31, 2009, the Company completed an additional private placement, issuing 6,625,000 units at $2.05 per unit, for gross proceeds of $13,581,250. Each unit consists of one common share and one common share purchase warrant, with each common share purchase warrant entitling the holder to purchase, subject to adjustment, one common share
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
3. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
4. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
6. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
7. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
8. PDL BioPharma Completes October 1 Special Dividend Payment
9. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
10. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
11. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... PARIS , July 6, 2015 ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... Japan,s Ministry of Health, ... Confocal Laser Endomicroscopy solution, the AQ-Flex 19 miniprobe. ... Cellvizio AQ -Flex™ 19 miniprobe is comprised of ...
(Date:7/6/2015)... 2015 Research and Markets( ... "Pharmaceutical Packaging Market in North America 2015-2019" report ... in North America to grow ... International regulations regarding safe drug delivery ... in turn fuels adoption of sustainable packaging. Various raw ...
(Date:7/6/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ) ... Market in the US 2015-2019" report to their ... market in the US to grow at a CAGR ... report covers the present scenario and the growth prospects ... the period 2015-2019. To calculate the market size, the ...
Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2
... BEVERLY HILLS, Calif., June 27, 2011 OXIS International, ... Paris: OXI) today announced that it has named former ...  The Company,s Board now has four members, including three ... bring an executive of Ken,s caliber to the OXIS ...
... 27, 2011 Columbia Laboratories, Inc. (Nasdaq: CBRX ... today announced that the U.S. Food and Drug Administration (FDA) ... PROCHIEVE ® (progesterone gel) for the reduction of risk ... in the mid-trimester of pregnancy. The acceptance of the NDA ...
Cached Medicine Technology:OXIS International Names Former Wal-Mart Executive Ken Eaton to Board of Directors 2OXIS International Names Former Wal-Mart Executive Ken Eaton to Board of Directors 3Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 2Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 3Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 4
(Date:7/6/2015)... ... July 06, 2015 , ... Invitation to Cover: , Most ... a large gap between the unmet health priorities in the region and the ... reduce unnecessary or ineffective treatments or procedures. , This milestone conference, sponsored by ...
(Date:7/6/2015)... ... 2015 , ... Understanding the new ICD-10 requirements is crucial ... transition. ADVOCATE, the only 100% radiology, revenue cycle management company in the nation, ... ten tips are timely and relevant guidelines to help radiology practices avoid coding ...
(Date:7/6/2015)... ... 2015 , ... Seedstock today announced Pierre Sleiman, founder and CEO of ... Sustainable Agriculture Conference – “Innovation and the Small Farmer” – to be held Nov. ... California-San Diego, will explore solutions and methodologies that small farmers and entrepreneurs are developing ...
(Date:7/6/2015)... ... , ... In a split second, breaking a bone can cause loss of ... fracture through the bone health screenings conducted by American Bone Health trained Peer Educators ... residents need this information to remain independent and strong for many more years,” according ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is ... area patients. Kybella is a non-surgical method to dissolve fat cells and ... moderate to severe fat deposits under the chin, commonly known as a double chin. ...
Breaking Medicine News(10 mins):Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:National Bone Health Screening and Awareness Day 2Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2
... As increasing numbers of childhood cancer patients survive into ... consideration in treatment, say senior cancer and fertility scientists. ... and New Zealand are diagnosed with cancer every year, ... at Melbourne’s Royal Children’s Hospital. ,“About ...
... to a new research from UT Southwester Medical Center, children ... more at risk for strokes later in life. // ... cranial radiation therapy to kill the cancer showed even greater ... which appears in the Nov. 20 issue of the Journal ...
... eggs with red yolk are considered to be more nutritious ... eggs are natural – says a recent investigations. ... investigation that found that the red color found in many ... as Sudan Red I, a toxic industrial colorant, being used ...
... a connection between chronic lung diseases and rheumatoid ... estimates about the strength of this connection // ... criteria for these diseases. Addressing this problem, Mayo ... of Rheumatology Annual Meeting on Nov. 11 confirming ...
... Researchers at the University of Pennsylvania School of Medicine ... leukemia (AML). Several lines of evidence point to a ... creatures that took over the starship Enterprise in the ... fruit flies. ,“Tribbles had never been directly ...
... declines in their memory during and after menopause, a change ... changes they weather during that time. // ,Now, ... hormone therapy might help women retain certain memory functions. In ... Clinical Endocrinology & Metabolism, they report that a group of ...
Cached Medicine News:Health News:Preserving Fertility for Child Cancer Patients 2Health News:Childhood Survivors Of Brain Tumors More At Risk For Strokes Later In Life 2Health News:Childhood Survivors Of Brain Tumors More At Risk For Strokes Later In Life 3Health News:Fear Of Cancer Due To Duck Egg Contamination In China 2Health News:Study Examines Link Between Rheumatoid Arthritis and Chronic Lung Diseases 2Health News:"Tribbles" Protein Implicated in Leukemia 2Health News:Hormone Therapy May Improve the Trip Down Memory Lane 2
ThermalSeal RT (2mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates....
Sealing tape featuring 3M adhesive technology. Superior optical properties. Low autofluorescense. Some residue will remain if using DMSO. Non-tacky to skin and gloves....
Sealing tape featuring 3M adhesive technology. Repeat piercing with minimal residue. Not recommended for DMSO. Non-tacky to skin and gloves....
Sealing tape, white Rayon, breathable, NS...
Medicine Products: